[June 17, 2015] |
|
Day Three of the 2015 BIO International Convention to Feature a Keynote Luncheon with Dr. Eric Topol and Evening Keynote with Jazz Musician Wynton Marsalis
The 2015
BIO International Convention, the world's largest biotechnology
event, started this week at the Pennsylvania Convention Center and will
run through Thursday, June 18. Hosted by the Biotechnology
Industry Organization, this year's event is expected to attract more
than 3,000 biotechnology companies and more than 15,000 attendees from
48 states and 65 countries.
Wednesday Convention Highlights Include:
-
Keynote Luncheon: Eric
Topol, Cardiologist and Digital Health Expert, Wednesday,
June 17
Wednesday's Keynote Luncheon will feature Dr. Eric
J. Topol, the Dean of Digital Medicine and preeminent speaker on the
future of healthcare. He was voted the #1 Most Influential Physician
Executive in the United States in a poll conducted by Modern
Healthcare. Dr. Topol is widely recognized as the leading authority on
digital medicine and its impact on every branch of healthcare. 12:00
- 1:30 PM | Terrace Ballroom, Level 400
PLEASE NOTE:
Photography is permitted during the first 3 minutes of Topol's speech
only. If you would like to send someone to the photography pool,
please RSVP to [email protected],
and meet at the back of the room, stage left, at 12:40 pm to be
escorted to the photo staging area.
-
Wednesday Evening Keynote: Wynton
Marsalis, Internationally Acclaimed Jazz Musician,
Wednesday, June 17
Wynton Marsalis is an internationally
acclaimed musician, composer, bandleader, educator and a leading
advocate of American culture. He is the world's first jazz artist to
perform and compose across the full jazz spectrum from its New Orleans
roots to bebop to modern jazz. By creating and performing an expansive
range of brilliant new music for quartets to big bands, chamber music
ensembles to symphony orchestras, tap dance to ballet, Wynton has
expanded the vocabulary for jazz and created a vital body of work that
places him among the world's finest musicians and composers. Marsalis
will address the parallels of music and entrepreneurship and the
challenges and opportunities of biotech. Corresponding themes include
creating new ideas without capital, and the perseverance needed to
bring an idea to fruition. He will also address art as a collaborative
enterprise and how this can be applied to any organization. Marsalis's
message of entrepreneurship, nurturing ideas from concept to reality
and collaboration - as well as the overarching theme of innovation -
are concepts that are also woven into each of our professional and
personal lives. 6:00 - 7:00 PM | Ballroom AB, Level 300
-
Super Session: Investment
Incentives to Combat Antimicrobial Resistance (AMR),
Wednesday, June 17
Globally, antimicrobial resistance has
become one of the most significant public health issues, affecting all
countries and causing increasing hospitalizations, extended illness,
and escalating healthcare costs. Over the last few years numerous
analyses have demonstrated the gaps and market failures that have
slowed the development of novel products, especially antibiotics.
Governments, non-governmental organizations, and industry are engaged
in partnering models to stimulate investment in new modalities to best
address this public health crisis. Panelists will discuss various
global initiatives; the role and importance of antibiotics,
antibodies, vaccines and diagnostics in global stewardship efforts;
and what incentives will best encourage industry R&D. 10:00
- 11:30 AM | Room 114
-
Super Session: Accelerating
Innovation in the 21st Century, Wednesday, June 17
Recent
scientific advancements mean that bioscience is on the cusp of
delivering increasingly targeted, specialized, advanced treatments to
patients. The promise of the science, however, demands
investment, collaboraions, the support of regulatory authorities and
government. The panel will convene US and European thought
leaders to discuss and debate how to better ensure the promise is
realized.
2:00 - 3:30 PM | Room 114
-
Personalized
Medicine Plenary with Dr. Francis Collins, Wednesday, June
17
With the announcement of President Obama's Precision
Medicine Initiative, more attention and focus has been placed on this
bold new effort to revolutionize how we improve health and treat
disease. Dr. Francis Collins, Director of the National Institutes of
Health, will kick off the Personalized Medicine & Diagnostics track
with a keynote addressing the potential of a more precise,
personalized approach to medicine. He will describe NIH's efforts to
foster research in precision medicine, discuss potential barriers to
its advancement into the healthcare and consumer ecosystem, and
highlight how we might best overcome those barriers to move medicine
forward. 9:00 - 10:00 AM | Room 105AB
-
The
Impact of USPTO Inter Partes Review Proceedings on (Bio)Pharma,
Wednesday, June 17
Inter Partes Review Proceedings (IPRs)
before the U.S. Patent and Trademark Office-with a lower burden of
proof, lower costs and speedier resolution than district court
proceedings-have become a preferred tactic for challenging U.S.
patents. Some 77.2 percent of cases have gone to trial. Final written
decisions issued in 120 proceedings have led to cancellation of 76.2
percent of the challenged claims. This session will focus on the
fairness of IPRs and how generic, brand and non-practicing entities
are using IPRs strategically to force settlements, achieve licensing
objectives and secure freedom to operate. Also discussed will be the
impact on raising capital, partnering and patent portfolio development. 2:00
- 3:15 PM | Room 109AB
Upcoming Convention Highlights Include:
-
Super Session: Riding
the Bull Market: What's in Store for Biotech Dealmakers in 2015?,
Thursday, June 18
Campbell Alliance and BIO are pleased to
present updated findings from two unique forward-looking measures of
deal-making in the industry - the Campbell Alliance Dealmakers'
Intentions Study and the BIO One-on-One Partnering Forecast. Based
on a survey of more than 150 industry executives and business
development professionals, Dealmakers' Intentions provides insight
into what will likely drive the industry's partnering and M&A efforts
moving forward, and the implications for deal-making over the next
year or more. Now in its seventh year, analysis in 2015 will
include year-over-year trends, additional deal metrics, and broader
M&A data. 10:00 - 11:30 AM | Room 114
-
Super Session: The
Next Step: How Companies Build Successful Therapeutic Franchises from
the Ground Up, Thursday, June 18
Whether you're
an established commercial entity or an emerging biotech company that
is commercializing for the first time, building a franchise in a new
therapeutic area from the ground up raises a host of questions: how
much risk should be accepted, how quickly, and how large, should a
salesforce be built, what capabilities are needed, and is a partner
needed to fully leverage the opportunity. It is known that your first
moves into a new therapeutic area are critical and that your first
year on the market will likely dictate the product's success.
Panelists will provide real life examples of what it takes to build a
therapeutic franchise through a moderated panel discussion. 12:00
- 1:30 PM | Room 114
-
Super Session: Scientific
American Worldview - Biotech: The Many Spheres of Influence,
Thursday, June 18
Progress, policies and people drive life
science innovation. Which ones are the most noteworthy? And which ones
exert the most global influence? This year's Worldview, the annual
collaborative edition from Scientific American, showcases the 100 most
influential people in biotechnology. Come to the SCIENTIFIC AMERICAN
Worldview super session to hear a dynamic panel of international
luminaries opine on the future of innovation in a lively conversation,
and perhaps even debate the very meaning of the word "influence."
Moderated by television and radio journalist, David Brancaccio, host
of Marketplace Morning Report, this event will explore key themes from
the edition and offer fresh perspectives on international life science
development. 2:00 - 3:30 PM | Room 114
Follow the 2015 Convention @BIOConvention,
and join the conversation and @IAmBIOtech.
Media registration is open from 8:00am - 5:30pm at the Pennsylvania
Convention Center. The majority of attendees, 70 percent, are c-level
executives. They split evenly from large companies of 500 or more
employees and small companies of 50 employees or less.
The BIO International Convention is the largest global event for the
biotechnology industry and attracts the biggest names in biotech, offers
key networking and partnering opportunities, and provides insights and
inspiration on major trends affecting the industry. The Convention will
highlight the latest trends and the newest opportunities for executives,
investors, scientists, policy leaders, and media from around the world.
Speakers at the sessions will share breakthroughs in medicine,
diagnostics, the environment, energy production, business operations,
financing, partnerships, policy issues and food and agriculture. Visit http://convention.bio.org/program/
for the most up-to-date program and speaker information.
Upcoming BIO Events
World
Congress on Industrial Biotechnology July 19-22, 2015 Montréal,
Canada
BIO
Latin America Conference October 14-16, 2015 Rio de
Janeiro, Brazil
BIO
Investor Forum October 20-21, 2015 San Francisco, CA (News - Alert)
About BIO
BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO's blog chronicling "innovations transforming our world" and the
BIO Newsletter is the organization's bi-weekly email newsletter. Subscribe
to the BIO Newsletter.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150617005858/en/
[ Back To TMCnet.com's Homepage ]
|